Medical Program: An NSCLC Expert’s Take on Aggressive Disease Management

An NSCLC Expert’s Take on Aggressive Disease Management

An NSCLC Expert’s Take on Aggressive Disease Management
RestartResume
When looking after patients with non-small cell lung cancer, an aggressive disease calls for an aggressive treatment strategy.
  • Overview

    What’s the best course of action for those patients with non-small cell lung cancer (NSCLC) that’s rapidly growing? Join Dr. Edward Kim, Chair of Solid Tumor Oncology and Investigational Therapeutics at Levine Cancer Institute, as he reviews some of the methods that aim to achieve the best response rate in these patients.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Facebook Comments

NEW FEATURES:

Register

Join the Global Oncology Academy of learners.
Registration is free and easy.

Register Now